USPTO serial 79209931
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical, biological and biotechnical products, compounds and preparations for scientific use, namely, reagents for use in scientific apparatus for chemical or biological analysis; chemical, biochemical, biological and biotechnological products and preparations for scientific use for identification of primary compounds with biological activity, namely, reagents for use in scientific apparatus for chemical or biological analysis; chemical, biochemical, biological, biotechnological products for laboratory analysis other than for medical or veterinary use, namely, reagents for use in scientific apparatus for chemical or biological analysis; diagnostic preparations other than for medical or veterinary use; chemical reagents other than for medical or veterinary use | SECTION 71 - CANCELLED | — |
| 005 | Chemical, biochemical, biological and biotechnological products, compounds and preparations for medical, pharmaceutical or veterinary use, namely, vaccines or chemical preparations for the diagnosis of pregnancy; chemical, biochemical, biological and biotechnological products, compounds and preparations for medical, pharmaceutical or veterinary use in the nature of reagents for medical use for identification of primary compounds with biological activity; chemico-pharmaceutical products, namely, vaccines; bacterial and bacteriological preparations for medical or veterinary use; diagnostic preparations for medical or veterinary use, chemical reagents for medical or veterinary use; cultures and preparations of microorganisms for medical or veterinary use | SECTION 71 - CANCELLED | — |
| 042 | Scientific and industrial research in the field of pharmaceuticals; scientific research in pharmacology and pharmacochemistry; scientific research and technical development of biochemical analysis and biological analysis techniques; scientific analysis, consultancy and information services relating to biology and biotechnology; research and development of new products in the field of pharmacy, biology and biotechnology, medicine and science; research laboratories, namely, scientific and medical research laboratory services; scientific research services provided by engineers in the field of pharmacology, medicine and science | SECTION 71 - CANCELLED | — |
| 044 | Health care services, namely, medical analysis services relating to pharmaceutical treatment; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals and medicines; medical and pharmaceutical consultation | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 29, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jan 15, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 15, 2026 | INPC | INVALIDATION PROCESSED | — |
| Jul 22, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 22, 2024 | C71T | CANCELLED SECTION 71 | — |
| May 8, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 8, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 1, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 1, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 9, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 30, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Sep 7, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 16, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 16, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 8, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 8, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 20, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 20, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 31, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 14, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 12, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 12, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2018 | ALIE | ASSIGNED TO LIE | — |
| Dec 28, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 1, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 1, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 25, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 24, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 20, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 16, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 15, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |